Arginase Inhibitor in the Pharmacological Correction of Endothelial Dysfunction

This paper is about a way of correction of endothelial dysfunction with the inhibitor of arginase: L-norvaline. There is an imbalance between vasoconstriction and vasodilatation factors of endothelium on the basis of endothelial dysfunction. Among vasodilatation agents, nitrogen oxide plays the basi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pokrovskiy, Mihail V., Korokin, Mihail V., Tsepeleva, Svetlana A., Pokrovskaya, Tatyana G., Gureev, Vladimir V., Konovalova, Elena A., Gudyrev, Oleg S., Kochkarov, Vladimir I., Korokina, Liliya V., Dudina, Eleonora N., Babko, Anna V., Terehova, Elena G.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE-Hindawi Access to Research 2011
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3124670/
https://ncbi.nlm.nih.gov/pubmed/21747978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4061/2011/515047
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak